Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 18mg	18mg	Capsule	3,744,073 L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Tablet, controlled release	4,945,340 L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Suppository	4,153,817 L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Enema	2,791,161 L.L
J01CR02	POSMOX	G	Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg	1g	Powder	616,824 L.L
N02BE01	PARACETAMOL ARROW	G	Paracetamol - 1g	1g	Tablet	80,631 L.L
L04AD02	PROGRAF 1MG	B	Tacrolimus - 1mg	1mg	Capsule	L.L
L04AD02	PROGRAF 1MG	B	Tacrolimus - 1mg	1mg	Capsule	25,241,922 L.L
L04AD02	PROGRAF 1MG	B	Tacrolimus - 1mg	1mg	Capsule	25,241,922 L.L
N05AX08	PMS-RISPERIDONE	G	Risperidone - 1mg	1mg	Tablet	823,775 L.L
N05AX08	PMS-RISPERIDONE	G	Risperidone - 1mg/ml	1mg/ml	Solution	604,729 L.L
R05CB13	PULMOZYME	BioTech	Dornase alfa (desoxyribonuclease) - 2.5mg/2.5ml	2.5mg/2.5ml	Inhalation solution	L.L
R05CB13	PULMOZYME	BioTech	Dornase alfa (desoxyribonuclease) - 2.5mg/2.5ml	2.5mg/2.5ml	Inhalation solution	54,658,804 L.L
B05AA01	PLASBUMIN-20 ALBUMIN (HUMAN)	BioHuman	Albumin human - 20%	20%	Injectable solution	3,641,813 L.L
B01AB05	PARINOX 20	BioTech	Enoxaparin sodium - 2000IU (20mg)/0.2ml	2000IU (20mg)/0.2ml	Injectable solution	188,138 L.L
N05CM18	PRECEDEX (DEXMEDETOMIDINE)	B	Dexmedetomidine HCl - 200mcg/2ml	200mcg/2ml	Injectable solution	19,441,512 L.L
N05CM18	PROXIDA	G	Dexmedetomidine HCl - 200mcg/2ml	200mcg/2ml	Injectable concentrate for solution	1,771,184 L.L
G03DA04	PROGEST 200	G	Progesterone micronised - 200mg	200mg	Capsule, soft gelatin	411,216 L.L
V03AB35	PLIBADEX	G	Sugammadex - 200mg/2ml	200mg/2ml	Injectable solution	47,914,365 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	294,302 L.L
N06AB03	PMS-FLUOXETINE	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	592,635 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 20mg	20mg	Tablet, enteric coated	440,780 L.L
N06AB03	PROXETIN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	374,996 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 20mg	20mg	Tablet, enteric coated	837,214 L.L
N06AB05	PARLOTIN	G	Paroxetine (HCl) - 20mg	20mg	Tablet	894,999 L.L
N06AB05	PAXERA	G	Paroxetine (HCl) - 20mg	20mg	Tablet, film-scored	1,016,841 L.L
N06AB05	PMS-PAROXETINE	G	Paroxetine (HCl) - 20mg	20mg	Tablet	731,050 L.L
A02BC04	PARIET	B	Rabeprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	779,429 L.L

...